CHI Advisors as of Sept. 30, 2020
Portfolio Holdings for CHI Advisors
CHI Advisors holds 21 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repare Therapeutics Ord (RPTX) | 27.6 | $78M | 2.5M | 30.77 | |
| Pliant Therapeutics (PLRX) | 18.9 | $53M | 2.4M | 22.65 | |
| Inozyme Pharma (INZY) | 9.4 | $27M | 1.0M | 26.29 | |
| Larimar Therapeutics (LRMR) | 8.2 | $23M | 1.5M | 15.17 | |
| Keros Therapeutics (KROS) | 7.8 | $22M | 570k | 38.57 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 7.3 | $21M | 1.3M | 15.61 | |
| Akouos | 6.9 | $19M | 846k | 22.87 | |
| Orchard Therapeutics Ads | 4.3 | $12M | 2.9M | 4.11 | |
| American Well Corp Cl A | 2.6 | $7.4M | 248k | 29.64 | |
| Precision Biosciences Ord | 2.2 | $6.3M | 1.0M | 6.16 | |
| Ovid Therapeutics (OVID) | 1.3 | $3.5M | 618k | 5.74 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $2.3M | 583k | 4.01 | |
| Global Blood Therapeutics In | 0.5 | $1.4M | 26k | 55.12 | |
| Kezar Life Sciences | 0.4 | $1.2M | 247k | 4.84 | |
| G1 Therapeutics | 0.3 | $970k | 84k | 11.55 | |
| Myokardia | 0.3 | $954k | 7.0k | 136.29 | |
| Adverum Biotechnologies | 0.3 | $721k | 70k | 10.30 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $616k | 7.5k | 82.13 | |
| Blueprint Medicines (BPMC) | 0.2 | $603k | 6.5k | 92.77 | |
| Livongo Health | 0.2 | $510k | 3.6k | 140.11 | |
| Bluebird Bio (BLUE) | 0.2 | $432k | 8.0k | 54.00 |
